SHORT COMMUNICATION
Anti-lamin A/C antibodies in patients with Behçet’s disease
,
 
,
 
,
 
 
 
More details
Hide details
 
Submission date: 2016-03-16
 
 
Final revision date: 2016-04-09
 
 
Acceptance date: 2016-04-09
 
 
Publication date: 2018-10-30
 
 
Cent Eur J Immunol 2018;43(3):358-361
 
KEYWORDS
ABSTRACT
Lamin A/C has been identified as a target antigen of anti-endothelial cell antibodies in vasculitis. Behçet’s disease (BD) is a chronic vasculitis with unclear pathogenesis. Self-antibodies have been found to play an important role in the pathological process of BD. The aim of this study was to verify whether lamin A/C is an autoantigen of BD. First, the human lamin A/C protein was cloned and purified and verified by Western blotting. Next, a homemade ELISA kit was used to test the presence of anti-lamin A/C antibodies in BD patients. This is the first time it has been certified that lamin A/C is an autoantigen of BD. The reactivity of serum IgG against recombinant human lamin A/C was detected in 7 of 31 BD patients (23%) and 3 of 32 healthy controls (HC) (9%).
REFERENCES (13)
1.
Régent A, Lofek S, Dib H, et al. (2014): Identification of target antigens of anti-endothelial cell antibodies in patients with anti-neutrophil cytoplasmic antibody-associated vasculitides: A proteomic approach. Clin Immunol 153: 123-135.
 
2.
Régent A, Dib H, Ly KH, et al. (2011): Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach. Arthritis Res Ther 13: R107.
 
3.
Aydìntug AO, Tokgöz G, D’Cruz DP, et al. (1993): Antibodies to endothelial cells in patients with Behçet’s disease. Clin Immunol Immunopathol 67: 157-162.
 
4.
Cho SB, Ahn KJ, Kim do H, et al. (2012): Identification of HnRNP-A2/B1 as a target antigen of anti-endothelial cell IgA antibody in Behcet’s disease. J Invest Dermatol 132: 601-608.
 
5.
Chen P, Yang W, Tian Y, et al. (2015): Electron transfer flavoprotein subunit beta is a candidate endothelial cell autoantigen in Behçet’s disease. PLoS One 10: e0124760.
 
6.
Chen P, Shi L, Jiang Y, et al. (2014): Identification of heat shock protein 27 as a novel autoantigen of Behçet’s disease. Biochem Biophys Res Commun 456: 866-871.
 
7.
Chen P, Yan H, Tian Y, et al. (2015): Annexin A2 as a target endothelial cell membrane autoantigen in Behçet’s disease. Sci Rep 5: 8162.
 
8.
Xun Y, Chen P, Yan H, et al. (2014): Identification of prohibitin as an antigen in Behcet’sdisease. Biochem Biophys Res Commun 451: 389-393.
 
9.
International Study Group for Behçet’s Disease (1990): Criteria for diagnosis of Behçet’s disease. Lancet 335: 1078-1080.
 
10.
Goizet C, Yaou RB, Demay L, et al. (2004): A new mutation of the lamin A/C gene leading to autosomal dominant axonal neuropathy, muscular dystrophy, cardiac disease, and leuconychia. J Med Genet 41: e29.
 
11.
Nesher G, Margalit R, Ashkenazi YJ (2001): Anti-nuclear envelope antibodies: clinical associations. Semin Arthritis Rheum 30: 313-320.
 
12.
Goizet C, Yaou RB, Demay L, et al. (2008): Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apoptosis in immune-mediated vascular diseases and atherosclerosis. Blood 111: 4559-4570.
 
13.
International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD), (2014): The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28: 338-347.
 
eISSN:1644-4124
ISSN:1426-3912
Journals System - logo
Scroll to top